A new piece of the HIV infection puzzle explored

The human immunodeficiency virus type 1 (HIV-1) -- which was the focus of this study -- primarily infects certain cells of the immune system, and in this way massively weakens the body's own defence against diseases. The genetic material of the virus is securely packaged in a cone-shaped protein capsule known as the capsid, which is composed of individual hexagonal parts. Scientists knew how the capsid passes through the cell membrane into the interior of the cell during infection, but not how the virus's genetic material gets from the capsid into the cell nucleus, where it triggers the formation of new viruses.

This is where the work of the Heidelberg collaboration comes in. Using newly developed methods for 3D imaging of molecular complexes in virus-infected cells, the scientists succeeded in imaging the viral capsid directly during transport into the nucleus. "Until now, it was assumed that the capsid does not fit through the pores," explains Hans-Georg Kräusslich, Medical Director of the Zentrum für Infektiologie. "However, the question of how the viral genome gets into the cell nucleus is essential for its reproduction. Our results therefore support the search for new targets for future therapeutic approaches." Although current treatment options can suppress multiplication of the virus in the body, a true cure that eliminates the virus is not yet possible.

Platforms for high-resolution imaging

To get a detailed look at the inner workings of infected immune cells in the laboratory, the scientists used high-resolution imaging techniques. With the help of the Electron Microscopy Core Facility at Heidelberg University and the Cryo-Electron Microscopy Service Platform at EMBL Heidelberg, they combined light and electron microscopy methods. They were able to reconstruct 3D images of the molecular structures from their data. This allowed them to visualise the composition and architecture of the viral complexes and their interaction with cellular structures in high resolution. "The fruitful collaboration between our two institutions and the combination of specialised technology has helped to fit another piece of the HIV infection puzzle into the overall picture," says Martin Beck, a visiting group leader at EMBL and, since 2019, a Director and Scientific Member of the Max Planck Institute of Biophysics.